Cargando…

HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications

BACKGROUND: Stevens-Johnson syndrome (SJS) is an acute inflammatory vesiculobullous reaction of the skin and mucosa, often including the ocular surface, and toxic epidermal necrolysis (TEN) occurs with its progression. Although SJS/TEN is thought to be initiated by certain types of medication couple...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueta, Mayumi, Tokunaga, Katsushi, Sotozono, Chie, Sawai, Hiromi, Tamiya, Gen, Inatomi, Tsutomu, Kinoshita, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422242/
https://www.ncbi.nlm.nih.gov/pubmed/22912896
http://dx.doi.org/10.1371/journal.pone.0043650
_version_ 1782241018769309696
author Ueta, Mayumi
Tokunaga, Katsushi
Sotozono, Chie
Sawai, Hiromi
Tamiya, Gen
Inatomi, Tsutomu
Kinoshita, Shigeru
author_facet Ueta, Mayumi
Tokunaga, Katsushi
Sotozono, Chie
Sawai, Hiromi
Tamiya, Gen
Inatomi, Tsutomu
Kinoshita, Shigeru
author_sort Ueta, Mayumi
collection PubMed
description BACKGROUND: Stevens-Johnson syndrome (SJS) is an acute inflammatory vesiculobullous reaction of the skin and mucosa, often including the ocular surface, and toxic epidermal necrolysis (TEN) occurs with its progression. Although SJS/TEN is thought to be initiated by certain types of medication coupled with possible infection. In the present study we examined the multiplicative interaction(s) between HLA-A*0206 and 7 Toll-like receptor 3 (TLR3) Single-nucleotide polymorphisms (SNPs) in patients with SJS/TEN. PRINCIPAL FINDINGS: We analyzed the genotypes for HLA-A and 7 TLR3 SNPs in 110 Japanese SJS/TEN patients with severe ocular complications and 206 healthy volunteers to examine the interactions between the two loci. We found that HLA-A*0206 exhibited a high odds ratio for SJS/TEN (carrier frequency: OR = 5.1; gene frequency: OR = 4.0) and that there was a strong association with TLR3 rs.5743312T/T SNP (OR = 7.4), TLR3 rs.3775296T/T SNP (OR = 5.8), TLR3 rs.6822014G/G SNP (OR = 4.8), TLR3 rs.3775290A/A SNP (OR = 2.9), TLR3 rs.7668666A/A SNP (OR = 2.7), TLR3 rs.4861699G/G SNP (OR = 2.3), and TLR3 rs.11732384G/G SNP (OR = 1.9). There was strong linkage disequilibrium (LD) between rs.3775296 and rs.5743312 and between rs.7668666 and rs.3775290. The results of interaction analysis showed that the pair, HLA-A*0206 and TLR3 SNP rs3775296T/T, which exhibited strong LD with TLR3 rs.5743312, exerted more than additive effects (OR = 47.7). The other pairs, HLA-A*0206 and TLR3 rs.3775290A/A SNP (OR = 11.4) which was in strong LD with TLR3 rs7668666A/A SNP, and TLR3 rs4861699G/G SNP (OR = 7.6) revealed additive effects. Moreover, the combination HLA-A*0206 and TLR3 rs3775296T/T was stronger than the TLR3 rs6822014G/G and TLR3 rs3775290A/A pair, which reflected the interactions within the TLR3 gene alone. SIGNIFICANCE: By interaction analysis, HLA-A*0206 and TLR3 SNP rs3775296T/T, which were in strong LD with TLR3 SNP rs5743312T/T, manifested more than additive effects that were stronger than the interactions within the TLR3 gene alone. Therefore, multiplicative interactions of HLA-A and TLR3 gene might be required for the onset of SJS/TEN with ocular complications.
format Online
Article
Text
id pubmed-3422242
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34222422012-08-21 HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications Ueta, Mayumi Tokunaga, Katsushi Sotozono, Chie Sawai, Hiromi Tamiya, Gen Inatomi, Tsutomu Kinoshita, Shigeru PLoS One Research Article BACKGROUND: Stevens-Johnson syndrome (SJS) is an acute inflammatory vesiculobullous reaction of the skin and mucosa, often including the ocular surface, and toxic epidermal necrolysis (TEN) occurs with its progression. Although SJS/TEN is thought to be initiated by certain types of medication coupled with possible infection. In the present study we examined the multiplicative interaction(s) between HLA-A*0206 and 7 Toll-like receptor 3 (TLR3) Single-nucleotide polymorphisms (SNPs) in patients with SJS/TEN. PRINCIPAL FINDINGS: We analyzed the genotypes for HLA-A and 7 TLR3 SNPs in 110 Japanese SJS/TEN patients with severe ocular complications and 206 healthy volunteers to examine the interactions between the two loci. We found that HLA-A*0206 exhibited a high odds ratio for SJS/TEN (carrier frequency: OR = 5.1; gene frequency: OR = 4.0) and that there was a strong association with TLR3 rs.5743312T/T SNP (OR = 7.4), TLR3 rs.3775296T/T SNP (OR = 5.8), TLR3 rs.6822014G/G SNP (OR = 4.8), TLR3 rs.3775290A/A SNP (OR = 2.9), TLR3 rs.7668666A/A SNP (OR = 2.7), TLR3 rs.4861699G/G SNP (OR = 2.3), and TLR3 rs.11732384G/G SNP (OR = 1.9). There was strong linkage disequilibrium (LD) between rs.3775296 and rs.5743312 and between rs.7668666 and rs.3775290. The results of interaction analysis showed that the pair, HLA-A*0206 and TLR3 SNP rs3775296T/T, which exhibited strong LD with TLR3 rs.5743312, exerted more than additive effects (OR = 47.7). The other pairs, HLA-A*0206 and TLR3 rs.3775290A/A SNP (OR = 11.4) which was in strong LD with TLR3 rs7668666A/A SNP, and TLR3 rs4861699G/G SNP (OR = 7.6) revealed additive effects. Moreover, the combination HLA-A*0206 and TLR3 rs3775296T/T was stronger than the TLR3 rs6822014G/G and TLR3 rs3775290A/A pair, which reflected the interactions within the TLR3 gene alone. SIGNIFICANCE: By interaction analysis, HLA-A*0206 and TLR3 SNP rs3775296T/T, which were in strong LD with TLR3 SNP rs5743312T/T, manifested more than additive effects that were stronger than the interactions within the TLR3 gene alone. Therefore, multiplicative interactions of HLA-A and TLR3 gene might be required for the onset of SJS/TEN with ocular complications. Public Library of Science 2012-08-17 /pmc/articles/PMC3422242/ /pubmed/22912896 http://dx.doi.org/10.1371/journal.pone.0043650 Text en © 2012 Ueta et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ueta, Mayumi
Tokunaga, Katsushi
Sotozono, Chie
Sawai, Hiromi
Tamiya, Gen
Inatomi, Tsutomu
Kinoshita, Shigeru
HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
title HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
title_full HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
title_fullStr HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
title_full_unstemmed HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
title_short HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
title_sort hla-a*0206 with tlr3 polymorphisms exerts more than additive effects in stevens-johnson syndrome with severe ocular surface complications
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422242/
https://www.ncbi.nlm.nih.gov/pubmed/22912896
http://dx.doi.org/10.1371/journal.pone.0043650
work_keys_str_mv AT uetamayumi hlaa0206withtlr3polymorphismsexertsmorethanadditiveeffectsinstevensjohnsonsyndromewithsevereocularsurfacecomplications
AT tokunagakatsushi hlaa0206withtlr3polymorphismsexertsmorethanadditiveeffectsinstevensjohnsonsyndromewithsevereocularsurfacecomplications
AT sotozonochie hlaa0206withtlr3polymorphismsexertsmorethanadditiveeffectsinstevensjohnsonsyndromewithsevereocularsurfacecomplications
AT sawaihiromi hlaa0206withtlr3polymorphismsexertsmorethanadditiveeffectsinstevensjohnsonsyndromewithsevereocularsurfacecomplications
AT tamiyagen hlaa0206withtlr3polymorphismsexertsmorethanadditiveeffectsinstevensjohnsonsyndromewithsevereocularsurfacecomplications
AT inatomitsutomu hlaa0206withtlr3polymorphismsexertsmorethanadditiveeffectsinstevensjohnsonsyndromewithsevereocularsurfacecomplications
AT kinoshitashigeru hlaa0206withtlr3polymorphismsexertsmorethanadditiveeffectsinstevensjohnsonsyndromewithsevereocularsurfacecomplications